Report : Europe Antimicrobial Coatings for Medical Devices Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Coating Type (Antibacterial Coatings, Antiviral Coatings, and Others), Device Type (Catheters, Implantable Devices, Surgical Instruments, and Other Devices), Material [Metallic Coatings (Copper Coatings, Silver Coatings, and Other Metallic Coatings) and Non-Metallic Coatings (Polymeric Coatings, Organic Coatings, and Other Non-Metallic Coatings)], Application (General Surgery, Cardiovascular, Orthopedics, Gynecology, Dentistry, and Other Applications), and End User (Hospitals & Clinics, Diagnostic Centers, Ambulatory Surgical Centers, and Others)
At 13.1% CAGR, the Europe Antimicrobial coatings for medical devices market is speculated to be worth US$ 1,086.64 million by 2028, says Business Market Insights
According to Business Market Insights' research, the Europe antimicrobial coatings for medical devices market was valued at US$ 519.14 million in 2022 and is expected to reach US$ 1,086.64 million by 2028, registering a CAGR of 13.1% from 2022 to 2028. Elevating prevalence of hospital acquired infections (HAIs) and burgeoning use and demand of medical implants are some of the major factors propelling the growth of the market.
Healthcare-associated infections (HAIs) include catheter-associated urinary tract infections, central line-associated bloodstream infections, and ventilator-associated pneumonia. These infections may also occur at surgery sites and are known as surgical site infections. Moreover, as published by National Healthcare Safety Network (NHSN) January 2022 report, Urinary tract infections (UTIs) are the fifth most common type of healthcare-associated infection. UTIs account for more than 9.5% of conditions reported by acute care hospitals. Catheter-Associated Urinary Tract Infection (CAUTI) is an infection of the urinary tract caused by urinary catheters that are placed to drain urine from the bladder. CAUTI is one of the most common infections among UTIs acquired in the hospital. The Centers for Disease Control and Prevention (CDC) published in 2020, that approximately 75% of infections are associated with a urinary catheter. Around 15% to 25% of hospitalized patients receive urinary catheters during their hospital stays. The most important risk factor for developing a CAUTI is prolonged urinary catheter use. Complications associated with CAUTI cause discomfort to the patient, long hospital stays, increased treatment costs, and even mortality. Additionally, as per CDC it has been estimated that more than 13,000 deaths are annually associated with UTIs. Acute uncomplicated cystitis results in an estimated 6 days of discomfort, leading to approximately 7 million office visits per year with associated costs of US$ 1.6 billion. Thus, HAIs are imposing a high economic burden on the healthcare system. The increasing incidence of CAUTI complements the rise in the use of antimicrobial coatings, therefore driving the market.
On the contrary, tedious regulatory approval of antimicrobial coating products is acting as a restraining factor.
Based on coating type, the Europe antimicrobial coatings for medical devices market is segmented into antibacterial coatings, antiviral coatings, and others. The antibacterial coatings segment held 48.7% market share in 2022, amassing US$ 253.96 million. It is projected to garner US$ 543.08 million by 2028 to expand at 13.5 % CAGR during 2022-2028.
Based on device, the Europe antimicrobial coatings for medical devices market is categorized into catheters, implantable devices, surgical instruments, and other devices. The catheters segment held 32.4% market share in 2022, amassing US$ 169.01 million. It is projected to garner US$ 365.68 million by 2028 to expand at 13.7% CAGR during 2022-2028.
Based on material, the Europe antimicrobial coatings for medical devices market is categorized into metallic coatings and non-metallic coatings. The metallic coatings segment held 58.2% market share in 2022, amassing US$ 303.38 million. It is projected to garner US$ 649.92 million by 2028 to expand at 13.5% CAGR during 2022-2028.
Based on application, the Europe antimicrobial coatings for medical devices market is categorized into general surgery, cardiovascular, orthopedics, gynecology, dentistry, and other applications. The general surgery segment held 32.0% market share in 2022, amassing US$ 166.48 million. It is projected to garner US$ 356.10 million by 2028 to expand at 13.5% CAGR during 2022-2028.
Based on end user, the Europe antimicrobial coatings for medical devices market is categorized into hospitals and clinics, diagnostic centers, ambulatory surgical centers, and others. The hospitals and clinics segment held 32.9% market share in 2022, amassing US$ 171.52 million. It is projected to garner US$ 370.28 million by 2028 to expand at 13.7% CAGR during 2022-2028.
Based on country, the Europe antimicrobial coatings for medical devices market has been segmented into Germany, the UK, France, Italy, Spain, and Rest of Europe. Our regional analysis states that Germany captured 24.4% market share in 2022. It was assessed at US$ 127.31 million in 2022 and is likely to hit US$ 276.25 million by 2028, exhibiting a CAGR of 13.8% during the forecast period.
Key players dominating the Europe antimicrobial coatings for medical devices market are The Dow Chemical Company; PPG Industries, Inc.; Microban International; Covalon Technologies Ltd.; DSM; Specialty Coating Systems Inc.; and BioInteractions among others.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com